Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Jones has nothing to disclose.
Conflict of interest: Dr. Nightingale reports grants from Medical Research Council (MRC), outside the submitted work;.
Conflict of interest: Dr. Burhan reports grants from Astra Zeneca Grant: Respiratory High Risk Asthhma Clinic Proposal - 2019-055, personal fees from Novartis Advisory Board Attendance Fee, personal fees from Astra Zeneca Speaking Fees, personal fees from Chiesi Speaking Fees, personal fees from GSK Speaking Fees, other from Travel, Accomodation and Attendance Fees for European Respiratory Society Meeting, Paris, 2018, from Health Foundation Innovating for Improvement Round 6 Grant: Improving Heroin Smokers' access to COPD Community Services, outside the submitted work;.
Conflict of interest: Outside of this work has previously received honorarium from GSK, AstraZeneca, Chiesi and Pfizer and non-financial support from Napp. All other authors have no declarations.
Conflict of interest: Dr. BARBER has nothing to disclose.
Conflict of interest: Dr. Bond has nothing to disclose.
Conflict of interest: Dr. Parker has nothing to disclose.
Conflict of interest: Dr. Duffy has nothing to disclose.
Conflict of interest: Dr. Hampshire has nothing to disclose.
Conflict of interest: Dr. Gautam has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Copyright ©The authors 2021
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org